Guideline-directed medical therapy (GDMT) of patients with heart failure delivered virtually by physician-pharmacist teams was safe and improved GDMT across several hospitals in an integrated
In a Perspective article calling for better systems of prior authorization for prescription drugs, authors write that Medicare Part D is a good place to
Integration of precision health–derived interventions “may offer new opportunities for analytics-based geriatric medicine that accommodates individual heterogeneity but allows for more flexible and resource-efficient population-level
Using the example of potassium supplements remaining in a patient’s drug regimen after discontinuation of loop diuretics, authors remind clinicians to be aware of the
In the large, 6-month Care Homes Independent Pharmacist Prescriber Study (CHIPPS), weekly visits to care homes by pharmacist independent prescribers (PIPs) significantly reduced the Drug Burden
In a Sept. 2021 survey of U.S. healthcare practitioners (HCP), large percentages report personally receiving COVID-19 vaccines plus boosters and making strong vaccine recommendations to
With the federal public health emergency ending on May 11, the U.S. Department of Health and Human Services has released a “transition roadmap” that discusses
The FDA last week dropped the emergency use authorization requirement that patients have positive test results before prescribing of the antiviral products ritonavir-boosted nirmatrelvir (Paxlovid)
The challenges of maintaining an adequate supply of prescription drugs in the U.S. are many, starting with the numbers: more than 20,000 approved prescription drug
Patients appreciate “accurate, real-time information on medication costs to inform decision-making,” researchers report. While healthcare providers can use real-time benefit tools (RTBTs) to facilitate conversations